All EDQM press releases
Outcome of the 163rd Session of the European Pharmacopoeia Commission
During its 163rd session, held in Strasbourg on 19-20 March 2019, the European Pharmacopoeia (Ph. Eur.) Commission elected Prof. Torbjörn Arvidsson (Sweden) as its Chair. As the 19th Chair of the Ph. Eur. Commission since its establishment in 1964, Prof. Arvidsson will be supported by two...
Joint EDQM-USP symposium illustrates use of pharmacopoeial reference standards
Established specifically for their intended use, pharmacopoeial reference standards are thoroughly characterised and their uses may go beyond those described in compendia, although a clear-cut distinction between quantitative use and qualitative use is essential.
20 years of sampling & testing programme for medicines authorised for the EU
The European Directorate for the Quality of Medicines & Healthcare (EDQM) and the European Medicines Agency (EMA) have reviewed EMA’s sampling and testing programme for centrally authorised medicines on the EU/EEA market, which has been organised yearly since 1998.
EDQM and EU Commission discuss improving plasma supply management and donor protection
The EDQM and the European Commission (EC) brought together stakeholders involved in the field of plasma to discuss ways forward for improving plasma supply management and donor protection, during a symposium organised in Strasbourg on 29 and 30 January 2019.
EDQM welcomes WHO recommendation to discontinue innocuity test in guidelines on vaccines and biologicals
The EDQM has welcomed the recommendation of the WHO Expert Committee on Biological Standardization (ECBS) to omit the abnormal toxicity test (also called the innocuity test) in all future WHO documents on vaccines and other biological products, and to disregard the inclusion of this test in...
